5. Diabetes on Five Continents - Emerging Trends

Saturday, September 16, 2000

08:45-09:00 Welcome and Introduction
Global Overview of Diabetes
09:00-09:30 Diabetes Trends in Europe
Phillipe Passa, France
09:30-10:00 Diabetes Trends in Asia
Ryuzu Kawamori, Japan
10:00-10:30 Diabetes Trends in Africa
Ayesha Motala, South Africa
10:30-10:45 Coffee Break
10:45-11:15 Diabetes Trends in North America
Jay Skyler, USA
11:15-11:45 Diabetes Trends in Latin America
Pablo Aschner, Colombia
11:45-12:15  Evaluating the costs of diabetes therapy
Andrew Morris, UK
12:15-12:45 Challenges to optimal metabolic control 
Andreas Liebl, Germany
12:45-13:45 Lunch Break
One World - Options for Treatment - Evidence Based Medicine
13:45-14:15 A Review of Insulin Therapy in North America
Matthew Riddle, USA
14:15 -14:45 A Review of Insulin Therapy in Europe
Werner Scherbaum, Germany
14:45-15:15 Overview of Insulin glargine
Philip Home, UK
15:15-15:45 Patients' perceptions of diabetes therapy
Clare Bradley, UK
15:45-16:00 Coffee Break
16:00-16:30 Combination therapy with glimepiride and metformin vs glimepiride alone in Type 2 patients
Guillame Charpentier, France
16:30-17:00 Combination therapy - optimizing metabolic control
Hannele Yki-Jarvinen, Finland
17:00-18:00 Managing multiple risk factors - The MicroHOPE study
Herzel Gerstein, Canada
18:00 Closing remarks
Paul Zimmet, Australia
Evening gala dinner immediately following the symposium.


Intercontinental Hotel, Bethlehem


Carl-Erik Mogensen, Denmark
Paul Zimmet, Australia


Aventis Pharmaceuticals

FOR GENERAL, REGISTRATION AND ABSTRACT ENQUIRIES
Carolyn Wilkinson
Scientific Director, Injectable Insulins
Global Marketing and Medical Affairs
Aventis Pharmaceuticals
Bridgewater, New Jersery, USA
Tel: +1 908 231 5830
Fax: +1 908 231 5839
E-mail: calrolyn.wilkinson@aventis.com

FOR TRAVEL AND ACCOMMODATION ENQUIRIES:
Weronika Bugge
Best Concept GmbH, Germany
Fax: +49 6104 2010